EJ
Edward J Dulac III sold $91K of NTLA stock
Edward J Dulac III, EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA), sold 8,111 shares of NTLA stock worth $91K, per an SEC Form 4 filed Jul 24, 2026.
It was an open-market sale.
The trade happened on Jul 22, 2026, 2 days before it was made public.
NTLA has moved +2.5% since the trade date, from $11.13 to $11.41 (Nov 11, 2026 close).
- Traded
- Jul 22, 2026
- Disclosed
- Jul 24, 2026
- Filing delay
- 2 days
- Price since
- +2.5%
- Role
- EVP, Chief Financial Officer
- Source
- SEC Form 4